BE Board:Archives Academic Industrial Seminar Series: Difference between revisions
(New page: {{Template:BE Board}} <div style="padding: 10px; width: 720px; border: 5px solid #2D9258;"> ==2004-2005== *September 23, 2005 - * Special Bioethics Seminar * [http://www.holycross.edu/d...) |
No edit summary |
||
Line 2: | Line 2: | ||
{{Template:BE Board}} | {{Template:BE Board}} | ||
<div style="padding: 10px; width: 720px; border: 5px solid #2D9258;"> | <div style="padding: 10px; width: 720px; border: 5px solid #2D9258;"> | ||
==Back to [[BE_Board:Archives_Academic | Academic Archives]] page== | |||
==2004-2005== | ==2004-2005== | ||
Latest revision as of 17:30, 28 October 2011
For current website see begradboard.mit.edu
Back to Academic Archives page
2004-2005
- September 23, 2005 - * Special Bioethics Seminar *
Stempsey (College of Holy Cross)
- October 28, 2005 - * Special Bioethics Seminar *
Thomas Shannon (Worcester Polytechnic Institute)
- December 2, 2005
Mark Trusheim (Massachusetts Biotechnology Council) - 56-114 1:30 - 2:30 pm
- July 22, 2005
Dr. Paul Mason (Genzyme) "Drug discovery at Genzyme"
- June 10, 2005
Dr. Gyan Bhanot (IBM Life Sciences) "Systems biology and supercomputing at IBM Life Sciences"
- May 20 , 2005
Dr. Damon Demady (Biogen Idec) "Challenges of drug development: By the book vs. reality"
- April 22, 2005
Dr. Jinping Gan (Bristol-Myers Squibb) "Reactive metabolites in drug discovery"
- April 15, 2005
John Essigmann (MIT BE & CEHS) "De-mystification of the grant application process for new academic investigators"
- April 8, 2005
Nancy Briefs (President & CEO of Percardia) "A long winding road: From patent to PMA"
- March 25, 2005
Dr. Can Ozbal (BioTrove Inc.) "Mass spectroscopy-based label-free ultra-high throughput screening for drug discovery"
- March 11, 2005
Dr. Jonathan Gertler (Adams Harkness) "Market dynamics & financial strategies in life science technologies"
- February 25, 2005
Dr. Cindy Xia (Millenium) "From ABC to SLC: Evaluation of drug transporters in drug discovery and development"
- February 11, 2005
Dr. Keith Hoffmaster (Pfizer Inc.) "ADME in drug discovery & cholestasis as a mechanism of hepatotoxicity"
- December 13 , 2004
Drs. Birgit Schoeberl & Brian Harms (Merrimack Pharmaceuticals Inc.) "Starting a career in industry as an MIT alum"
- November 22, 2004
Dr. Vicki Sato (President of Vertex Pharmaceuticals Inc.) "Careers in academia & in industry"
- October 5, 2004 (see picture :))
Prof. Michael Lysaght (Brown University) "After the PhD: Career decisions in biomedical engineering"